POZZI, Valentina
 Distribuzione geografica
Continente #
NA - Nord America 3.160
EU - Europa 2.544
AS - Asia 1.018
SA - Sud America 148
AF - Africa 105
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 1
Totale 6.980
Nazione #
US - Stati Uniti d'America 3.142
IT - Italia 688
SG - Singapore 383
UA - Ucraina 370
RU - Federazione Russa 299
IE - Irlanda 241
DE - Germania 213
HK - Hong Kong 208
CN - Cina 201
SE - Svezia 199
DK - Danimarca 140
BR - Brasile 139
FR - Francia 133
FI - Finlandia 106
TR - Turchia 97
KR - Corea 81
CI - Costa d'Avorio 79
GB - Regno Unito 62
AT - Austria 29
IN - India 27
MA - Marocco 14
BE - Belgio 13
CA - Canada 13
RO - Romania 13
NL - Olanda 11
PL - Polonia 7
ID - Indonesia 5
EU - Europa 4
HR - Croazia 4
ES - Italia 3
LT - Lituania 3
AE - Emirati Arabi Uniti 2
BD - Bangladesh 2
JP - Giappone 2
MX - Messico 2
PY - Paraguay 2
SM - San Marino 2
TH - Thailandia 2
TN - Tunisia 2
ZA - Sudafrica 2
AM - Armenia 1
AO - Angola 1
AR - Argentina 1
AU - Australia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BJ - Benin 1
CG - Congo 1
CH - Svizzera 1
CL - Cile 1
CO - Colombia 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
EC - Ecuador 1
EG - Egitto 1
ET - Etiopia 1
GE - Georgia 1
GT - Guatemala 1
GY - Guiana 1
HU - Ungheria 1
IQ - Iraq 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
MD - Moldavia 1
MU - Mauritius 1
PA - Panama 1
PE - Perù 1
PK - Pakistan 1
PT - Portogallo 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
UZ - Uzbekistan 1
VE - Venezuela 1
VN - Vietnam 1
Totale 6.980
Città #
Chandler 422
Jacksonville 382
Dublin 236
Boardman 232
Singapore 230
Hong Kong 208
Ashburn 205
Fairfield 202
Wilmington 148
New York 130
Marche 113
Des Moines 97
Lawrence 84
Princeton 83
San Mateo 80
Abidjan 79
Seattle 78
Houston 77
Ann Arbor 69
Moscow 65
Woodbridge 61
Cambridge 59
Turin 53
Ancona 50
Centro 37
San Diego 36
Beijing 30
The Dalles 30
Tolentino 27
Helsinki 23
Los Angeles 23
Shanghai 23
Vienna 20
Wuhan 20
Milan 19
Washington 19
Rome 18
London 17
Berlin 15
Aversa 14
Brussels 13
Guangzhou 13
Munich 13
Redmond 13
Turku 13
Brasov 12
Nuremberg 11
Civitanova Marche 10
Dallas 10
Wuxi 10
Delhi 9
Pune 9
Belo Horizonte 7
Boydton 7
Cagliari 7
Jiaxing 7
Livorno 7
Norwalk 7
Perugia 7
Pesaro 7
Porto 7
Frederico Westphalen 6
Jinhua 6
Brooklyn 5
Chennai 5
Iesi 5
Quanzhou 5
São Paulo 5
Torino 5
Toronto 5
Amsterdam 4
Ascoli Piceno 4
Boston 4
Falconara Marittima 4
Genoa 4
Heze 4
Ottawa 4
Radomsko 4
Rieti 4
San Francisco 4
Seoul 4
São Bernardo do Campo 4
Torre Del Greco 4
Yiwu 4
Zagreb 4
Atlanta 3
Clifton 3
Curitiba 3
Florence 3
Foggia 3
Frankfurt am Main 3
Izmir 3
Loro Piceno 3
Manassas 3
Marigliano 3
Montecassiano 3
Montelupone 3
Namhyang-dong 3
Pavia 3
Rio de Janeiro 3
Totale 4.165
Nome #
Inflammatory cytokines patterns in the placenta of pregnancies complicated by HELLP syndrome. 129
Involvement of transforming growth factor beta 1 in the transcriptional regulation of nicotinamide N-methyltransferase in clear cell renal cell carcinoma 126
Involvement of the oral cavity in psoriasis: results of a clinical study 123
Cancer stem cell enrichment is associated with enhancement of nicotinamide N-methyltransferase expression 118
Clinical performance and utility of a NNMT-based urine test for bladder cancer 117
Exploring the role of paraoxonase-2 in bladder cancer: analyses performed on tissue samples, urines and cell cultures 111
Betacyanins enhance vitexin-2-O-xyloside mediated inhibition of proliferation of T24 bladder cancer cells 109
Differential expression of nicotinamide N-methyltransferase in primary and recurrent ameloblastomas and odontogenic keratocysts 108
Espressione della trombomodulina placentare negli aborti spontanei ricorrenti. 107
Gene expression profile of cytokines in patients with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation with reduced conditioning. 107
Expression and prognostic significance of apoptotic genes in oral squamous cell carcinoma 103
RNA-Mediated Gene Silencing of Nicotinamide N-Methyltransferase Is Associated with Decreased Tumorigenicity in Human Oral Carcinoma Cells. 102
Apoptosis pathway is involved in hemolysis, elevated liver enzyme, and low platelet (HELLP) syndrome and intrauterine growth restriction (IUGR). 98
Identification and Characterization of Cancer Stem Cells from Head and Neck Squamous Cell Carcinoma Cell Lines 97
Nicotinamide N-methyltransferase in Non-small Cell Lung Cancer: Promising Results for Targeted Anti-cancer Therapy. 95
Analysis of tissue and salivary nicotinamide N-methyltransferase in oral squamous cell carcinoma: basis for the development of a noninvasive diagnostic test for early-stage disease. 93
Bladder Cancer Chemosensitivity is Affected by Paraoxonase-2 Expression 93
Inflammatory cytokines patterns in the placenta of pregnancies complicated by Hellp syndrome. 91
Role of nicotinamide N-methyltransferase in non-small cell lung cancer: in vitro effect of shRNA-mediated gene silencing on tumorigenicity 91
Clues to apoptosis pathway involvement in hemolysis, elevated liver enzyme, and low platelet (HELLP) syndrome and intrauterine growth restriction (IUGR). 90
Fattore di differenziamento eritrocitario (EDRF) nella patologia ostetrica. 87
Association of MiR-126 with Soluble Mesothelin-Related Peptides, a Marker for Malignant Mesothelioma. 87
Inflammatory cytokines pattern in recurrent miscarriage. 86
Upregulation of Tissue and Urinary Nicotinamide N-Methyltransferase in Bladder Cancer: Potential for the Development of a Urine-Based Diagnostic Test. 86
Expression of extracellular matrix and adhesion proteins in pelvic organ prolapse 86
Paraoxonase-2 Silencing Enhances Sensitivity of A375 Melanoma Cells to Treatment with Cisplatin 86
Nicotinamide N-methyltransferase in nonmelanoma skin cancers 83
Aspetti infiammatori, trombotici e immunitari nella biologia dell’aborto spontaneo ricorrente. 82
Pokemon proto-oncogene in oral cancer: potential role in the early phase of tumorigenesis. 82
Diagnostic and prognostic role of nicotinamide N-methyltransferase in cutaneous malignant melanoma 82
Inhibiting proliferation in KB cancer cells by RNA interference-mediated knockdown of nicotinamide N-methyltransferase expression. 79
Cytokine expression profile of selected cell populations from patients with chronic graft-versus-host disease after allogeneic bone marrow transplantation wih reduced conditioning. 79
Nicotinamide N-methyltransferase: potential involvement in cutaneous malignant melanoma 79
L'enzima nicotinamide N-Metiltrasferasi: un nuovo marker diagnostico e target terapeutico nel carcinoma orale 78
RNA-mediated gene silencing NNMT decreases tumorigenity in OSCC cells. 75
The involvement of inflammatory cytokines in the pathogenesis of recurrent miscarriage. 73
Enhanced expression of amyloid precursor protein in platelets from patients with Alzheimer’s disease and frontotemporal lobar degeneration. 73
Structural Basis of Substrate Recognition in Human Nicotinamide N-Methyltransferase. 72
Inflammatory cytokines pattern in recurrent miscarriage. 72
Evaluation of urinary Nicotinamide N-methyltransferase: a non-invasive diagnostic test for bladder cancer 72
Cancer stem cells from human tumor cell lines: molecular and phenotypic features 72
Association of miR-126 with soluble mesothelin-related peptides: a novel marker for malignant mesothelioma. 71
CSCs selection, characterization and tumorigenic potential in OSCC. 71
Espressione di Pokemon nel carcinoma orale. 70
Enhanced expression of nicotinamide N-methyltransferase in non-small cell lung cancer: potential for the development of a targeted anticancer therapy. 70
Natural extracts from the genus Beta and their cytotoxic activity on T24 human bladder cancer cells 70
Periodontal Disease: An Oral Manifestation of Psoriasis or an Occasional Finding? 69
Identification and characterization of cancer stem cells from Head and Neck squamous cell carcinoma cell line Hep-2. 68
Molecular and phenotypic characterization of cancer stem cells from human tumor cell lines 68
Pattern di espressione placentare delle citochine infiammatorie nella HELLP syndrome. 67
Nicotinamide N-methyltransferase gene silencing enhances chemosensitivity of melanoma cell lines 67
Paraoxonase-2 is upregulated in triple negative breast cancer and contributes to tumor progression and chemoresistance 66
Nicotinamide N-methyltransferase: a promising marker for oral cancer. 65
Nicotinamide N-methyltransferase: a new potential biomarker for cutaneous malignant melanoma 64
Salivary and tissue Nicotinamide N-methyltrasferase: potential use for early and non-invasive diagnosis of oral squamous cell carcinoma. 62
Quantitative analysis of Nicotinamide N-methyltransferase expression in urine and tumour tissue of bladder cancer patients and its potential relevance for disease detection. 61
Nicotinamide N-methyltransferase as potential diagnostic marker in patients with urinary bladder carcinoma: a real-time approach. 61
Paraoxonase 2 (PON2) expression in bladder cancer 61
Paraoxonase-2: a novel molecular target to enhance chemosensitivity in melanoma and triple negative breast cancer cells 60
Nicotinamide N-Methyltransferase upregulation correlates with tumour differentiation in oral squamous cell carcinoma 60
The Double-Edged Sword of Oxidative Stress in Skin Damage and Melanoma: From Physiopathology to Therapeutical Approaches 60
Nicotinamide n-methyltransferase: a new diagnostic marker and therapeutic target for oral carcinoma. 59
Neurotrophins and receptors pattern expression in placentas from pregnancies complicated by HELLP Syndrome and Intrauterine Growth Restriction (IUGR). 59
Enhanced expression of paraoxonase 2 in human bladder cancer 59
Nicotinamide N-Methyltransferase: a promising biomarker for early diagnosis and prognostic monitoring of oral squamous cell carcinoma. 58
Micro-RNA profiling identifies mir-126 as promising biomarker for prognosis and early detection of malignant mesothelioma. 58
RNA-mediated gene silencing of nicotinamide N-methyltransferase is associated with decreased tumorigenicity in human oral carcinoma cells. 58
Characterization of cancer stem cells from larynx and bladder carcinoma cell lines 57
The Utility of Nicotinamide N-Methyltransferase as a Potential Biomarker to Predict the Oncological Outcomes for Urological Cancers: An Update 57
Beyond Nicotinamide Metabolism: Potential Role of Nicotinamide N‐Methyltransferase as a Biomarker in Skin Cancers 57
Role Played by Paraoxonase-2 Enzyme in Cell Viability, Proliferation and Sensitivity to Chemotherapy of Oral Squamous Cell Carcinoma Cell Lines 56
Nicotinamide N-methyltransferase as effective diagnostic tool and promising therapeutic target for oral cancer. 56
Inflammatory cytokines and receptors in placentas from pregnancies complicated by HELLP syndrome. 56
Gene silencing of Nicotinamide N-methyltransferase in oral cancer cell lines: effects on tumor cell proliferation. 55
Nicotinamide N-methyltransferase: a potential target molecule for effective therapy and early diagnosis of oral squamous cell carcinoma. 55
Nicotinamide N-Methyltransferase as Promising Tool for Management of Gastrointestinal Neoplasms 53
L’enzima nicotinamide N-metiltrasferasi potenziale marcatore diagnostico e prognostico nel carcinoma renale. 53
Tissue and salivary Nicotinamide N-Methyltransferase: promising results for early and non-invasive diagnosis of oral squamous cell carcinoma. 52
Profilo dell’espressione dei geni coinvolti nel pathway dell’apoptosi nel carcinoma orale. 52
NNMT (nicotinamide N-methyltransferase). 51
Epithelial Biological Response to Machined Titanium vs. PVD Zirconium-Coated Titanium: An In Vitro Study 51
Recent Advances in the Management of Clear Cell Renal Cell Carcinoma: Novel Biomarkers and Targeted Therapies 49
FTIRM analyses as a tool to explore cisplatin sensitivity of oral squamous cell carcinoma cell lines after PON2 knockdown 47
Quantitative analysis of NNMT mRNA expression in urine and tumor tissue of bladder cancer patients and its potential relevance for disease detection. 47
Nicotinamide N-methyltransferase, a promising marker for human osteosarcoma 46
Nicotinamide N-methyltransferase: a potential prognostic marker for oral squamous cell carcinoma. 44
Nicotinamide N-methyltransferase: a new prognostic marker for oral squamous cell carcinoma. 43
Nicotinamide N-Methyltransferase as potential predictor of lymph node metastasis in Oral Squamous Cell Carcinoma. 43
Nicotinamide N-Methyltransferase in Head and Neck Tumors: A Comprehensive Review 42
Nicotinamide N-methyltransferase, a promising marker for human Merkel cell carcinoma 41
Real-Time PCR analysis of NNMT expression in urine and tumor tissue of bladder cancer patients and its potential relevance for disease detection. 41
Curcumin and its Analogues in Oral Squamous Cell Carcinoma: State-of-the-art and Therapeutic Potential 40
Paraoxonase-2 (PON2) is upregulated in triple negative breast cancer and contributes to the tumor progression and chemoresistance 39
Role of paraoxonase-2 in triple-negative breast cancer: effect of shRNA-mediated gene silencing on cell proliferation and chemosensitivity 39
Immunohistochemical expression of nicotinamide N-methyltransferase in lymph node metastases from cutaneous malignant melanoma 39
The Effect and the Potential Use of Magnetic–Dam Barrier in Guided Bone Regeneration: A Laboratory Study 38
Paraoxonase-2 expression in oral squamous cell carcinoma 38
Gene silencing of Nicotinamide N-methyltransferase in oral cancer cell lines: effects on tumor cell proliferation. 36
Contribution of the Paraoxonase-2 Enzyme to Cancer Cell Metabolism and Phenotypes 34
FTIRM: an analytical approach to test the effectiveness of cisplatin treatment on PON2 silenced otscc cells 34
Totale 6.982
Categoria #
all - tutte 44.845
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.845


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020166 0 0 0 0 0 0 0 0 0 0 67 99
2020/2021859 36 98 117 3 103 40 104 35 96 84 110 33
2021/2022628 29 167 14 23 0 19 23 59 33 60 49 152
2022/20231.409 100 170 101 119 83 194 18 88 336 13 121 66
2023/20241.136 169 26 82 126 145 183 14 34 20 90 52 195
2024/20251.707 287 144 101 46 108 30 185 74 400 153 179 0
Totale 7.299